Gray matter volume in women with the BRCA mutation with and without ovarian removal: evidence for increased risk of late-life Alzheimer's disease or dementia

  • 0Psychology, University of Toronto, Toronto, ON, Canada.
New York +

|

|

Summary

This summary is machine-generated.

Early ovarian removal in BRCA mutation carriers may increase dementia risk. Post-surgery estradiol therapy appears to mitigate gray matter loss, suggesting potential neuroprotection.

Area Of Science

  • Neuroscience
  • Oncology
  • Endocrinology

Background

  • Ovarian removal before natural menopause is linked to higher dementia risk, possibly due to lost estradiol.
  • Women with BRCA mutations undergo oophorectomy to reduce cancer risk, but neurological effects are understudied.
  • Previous studies suggest cortical thinning and cognitive changes after oophorectomy.

Purpose Of The Study

  • To investigate whole-brain gray matter volume differences in women with BRCA mutations before and after oophorectomy.
  • To compare neurological effects of oophorectomy with and without estradiol hormone therapy.
  • To assess the impact of BRCA mutations and early oophorectomy on brain structure.

Main Methods

  • Cross-sectional study using high-resolution quantitative MRI.
  • Compared gray matter volume in four groups: BRCA-positive pre-oophorectomy, post-oophorectomy without hormone therapy, post-oophorectomy with hormone therapy, and age-matched controls.
  • Analyzed whole-brain gray matter differences.

Main Results

  • Women with BRCA mutations (pre- and post-oophorectomy) showed significantly lower gray matter volume in medial temporal and frontal lobes.
  • Post-oophorectomy estradiol therapy group had fewer gray matter volume reductions compared to controls.
  • All BRCA mutation groups exhibited higher gray matter volume than controls, indicating plasticity.

Conclusions

  • BRCA mutations and early oophorectomy may contribute to increased late-life dementia risk.
  • Post-surgical estradiol therapy may help reduce gray matter loss in BRCA carriers who undergo oophorectomy.
  • Findings support the role of estradiol in maintaining brain structure and potentially mitigating dementia risk.